AU3929493A - Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) - Google Patents

Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Info

Publication number
AU3929493A
AU3929493A AU39294/93A AU3929493A AU3929493A AU 3929493 A AU3929493 A AU 3929493A AU 39294/93 A AU39294/93 A AU 39294/93A AU 3929493 A AU3929493 A AU 3929493A AU 3929493 A AU3929493 A AU 3929493A
Authority
AU
Australia
Prior art keywords
lnaa
amino acids
plasma concentrations
neutral amino
reducing post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39294/93A
Inventor
Judith J. Wurtman
Richard J. Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indevus Pharmaceuticals Inc
Original Assignee
Interneuron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharmaceuticals Inc filed Critical Interneuron Pharmaceuticals Inc
Publication of AU3929493A publication Critical patent/AU3929493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU39294/93A 1992-03-11 1993-03-11 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) Abandoned AU3929493A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84924692A 1992-03-11 1992-03-11
US849246 1992-03-11
PCT/US1993/002651 WO1993017670A1 (en) 1992-03-11 1993-03-11 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Publications (1)

Publication Number Publication Date
AU3929493A true AU3929493A (en) 1993-10-05

Family

ID=25305395

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39294/93A Abandoned AU3929493A (en) 1992-03-11 1993-03-11 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Country Status (6)

Country Link
EP (1) EP0630238A4 (en)
JP (1) JPH07507058A (en)
KR (1) KR950700073A (en)
AU (1) AU3929493A (en)
CA (1) CA2131801A1 (en)
WO (1) WO1993017670A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698525A (en) * 1989-04-03 1997-12-16 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
US5432162A (en) * 1989-04-03 1995-07-11 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
IE80469B1 (en) * 1993-09-13 1998-07-29 Elan Corp Plc Compositions for reducing fluctuations in plasma concentrations of large neutral amino acids and use thereof in therapy
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
ES2280602T3 (en) 2001-07-26 2007-09-16 Merck Patent Gmbh USE OF 2- (5- (4-FLUOROPHENYL) -3-PIRIDYLMETHYLAMINOME) -CROMANO AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4542123A (en) * 1982-01-11 1985-09-17 Massachusetts Institute Of Technology Composition and method for increasing brain tyrosine levels
JPS60221043A (en) * 1984-04-18 1985-11-05 Toyo Jozo Co Ltd Feed sugar block and breeding method using same
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4690820A (en) * 1985-06-07 1987-09-01 The State University Of New York High-caloric, high-fat dietary formula
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5206218A (en) * 1989-04-03 1993-04-27 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Also Published As

Publication number Publication date
WO1993017670A1 (en) 1993-09-16
EP0630238A4 (en) 1995-05-24
EP0630238A1 (en) 1994-12-28
JPH07507058A (en) 1995-08-03
CA2131801A1 (en) 1993-09-16
KR950700073A (en) 1995-01-16

Similar Documents

Publication Publication Date Title
AU7690794A (en) Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2
AU4024295A (en) Amino acid derivatives of paclitaxel
AU3387393A (en) Method of scavenging oxygen in aqueous systems
AU4840293A (en) Cloning and expression of pur protein
AU7720594A (en) Soft plasma ignition in plasma processing chambers
AU6691694A (en) Process for reducing the content of metal carbonyls in gas streams
AU2105992A (en) Aluminum welding process and mixture of reactants for use in such process
AU3475393A (en) Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
AU3929493A (en) Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
AU6818894A (en) Process for adjusting ion concentration in a patient and compositions therefor
AU5746496A (en) Benzisoxazole and indazole derivatives as antipsychotic agents
AU5292193A (en) N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents
AU5722694A (en) Novel amino acid derivatives
AU3092292A (en) Improvements in or relating to clamps for extending legs
EP0920325A3 (en) Tetrapeptide derivatives of dolastatin as antitumor agents
AU5883794A (en) Diazepin derivatives and antiviral compositions
AU7322596A (en) Improvements in and relating to single screw compressors
GB9418370D0 (en) Compositions for reducing fluctuations in plasma concentrations of large neutral amino acids and use thereof in therepy
AU5686794A (en) (2-quinoxalinyloxy)phenoxypropanoic acids and related derivatives as anticancer agents
AU8709491A (en) Apparatus for dissolution of gas in liquid
AU3354395A (en) Sodium percarbonate that is stable and excellent in solubility
AU8140394A (en) Use of copper (ii) methioninate as fungicide in viticulture
AU7465298A (en) Process of increasing calcium content in an aqueous solution
AU6530694A (en) Method of reducing halides in synthesis gas
AU6158696A (en) Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins